Halyard Health (HYH) Stake Decreased by ETRADE Capital Management LLC

ETRADE Capital Management LLC trimmed its stake in shares of Halyard Health (NYSE:HYH) by 10.1% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 9,286 shares of the medical instruments supplier’s stock after selling 1,046 shares during the quarter. ETRADE Capital Management LLC’s holdings in Halyard Health were worth $428,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in HYH. First Manhattan Co. lifted its position in shares of Halyard Health by 595.1% during the 4th quarter. First Manhattan Co. now owns 15,189 shares of the medical instruments supplier’s stock worth $701,000 after buying an additional 13,004 shares during the last quarter. Swiss National Bank lifted its position in shares of Halyard Health by 2.3% during the 4th quarter. Swiss National Bank now owns 78,700 shares of the medical instruments supplier’s stock worth $3,634,000 after buying an additional 1,800 shares during the last quarter. Fox Run Management L.L.C. bought a new stake in shares of Halyard Health during the 4th quarter worth $385,000. Suntrust Banks Inc. bought a new stake in shares of Halyard Health during the 4th quarter worth $330,000. Finally, Millennium Management LLC lifted its position in shares of Halyard Health by 107.7% during the 4th quarter. Millennium Management LLC now owns 215,689 shares of the medical instruments supplier’s stock worth $9,961,000 after buying an additional 111,849 shares during the last quarter. Hedge funds and other institutional investors own 90.51% of the company’s stock.

Several equities analysts have commented on HYH shares. Deutsche Bank increased their target price on Halyard Health from $42.00 to $50.00 and gave the company a “buy” rating in a research report on Thursday, May 3rd. Morgan Stanley increased their target price on Halyard Health from $48.50 to $52.00 and gave the company an “underweight” rating in a research report on Thursday, May 3rd. KeyCorp increased their target price on Halyard Health from $61.00 to $62.00 and gave the company an “overweight” rating in a research report on Thursday, May 3rd. Stifel Nicolaus increased their target price on Halyard Health from $52.00 to $58.00 and gave the company a “buy” rating in a research report on Thursday, May 3rd. Finally, Zacks Investment Research upgraded Halyard Health from a “sell” rating to a “hold” rating in a research report on Friday, May 4th. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $55.20.

Halyard Health stock opened at $54.01 on Tuesday. The company has a quick ratio of 2.96, a current ratio of 3.22 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $2.51 billion, a price-to-earnings ratio of 22.98, a PEG ratio of 3.40 and a beta of 1.62. Halyard Health has a 12 month low of $35.79 and a 12 month high of $54.46.

Halyard Health (NYSE:HYH) last posted its earnings results on Wednesday, May 2nd. The medical instruments supplier reported $0.76 EPS for the quarter, beating the consensus estimate of $0.17 by $0.59. The firm had revenue of $156.40 million during the quarter, compared to the consensus estimate of $155.08 million. Halyard Health had a return on equity of 7.90% and a net margin of 7.72%. The business’s quarterly revenue was up 7.3% on a year-over-year basis. During the same period last year, the company earned $0.48 earnings per share. research analysts anticipate that Halyard Health will post 1.77 EPS for the current year.

About Halyard Health

Halyard Health, Inc operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management.

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply